0
Skip to Content
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
EU Psychedelics Map
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
EU Psychedelics Map
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
EU Psychedelics Map
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Guest Posts
Support Us
  • Testimonies,
• 08/09/2022

Dave Pounds - MDMA for Alcohol Use Disorder

Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder
Previous

Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression

You Might Also Like

Related Embedded Video Item Thumbnail SA TAIP seminar | Tadeusz Hawrot - "Psychedelic advances in the EU"
Related Embedded Video Item Thumbnail The Right to Psychedelic-assisted Therapy (PAT) IN Europe with Marion Haberkamp
Related Embedded Video Item Thumbnail The importance of mental health | Tadeusz Hawrot - TVP World
Related Embedded Video Item Thumbnail Presentation of the results of ketamine-assisted therapy program for treatment resistant depression
Related Embedded Video Item Thumbnail Psychedelic Research & Access in Ukraine | European Parliament, May 6, 2026

Our Work

About
Why

Contact

tadeusz@parea.eu

© Parea 2024 | Privacy Policy